Eplerenone

Etoricoxib Intermediate

Etoricoxib Intermediate

Etoricoxib is a COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. 


X
Provide Us More Details
Purpose of Requirement:

Reselling End Use Raw Material

X

Looking for Eplerenone ?

    country-ico

    We will contact you soon !

    Sanjay Totre

    (Managing Director)

    Yashica Pharmaceuticals Private Limited

    Syndicate, Thane, Maharashtra, India

    More Categories

    View All Categories »
    Send SMS
    Contact Us